Evaluation of organ motion-based robust optimisation for VMAT planning for breast and internal mammary chain radiotherapy.

Conclusions: Organ motion-based robust optimisation VMAT is able to produce clinically acceptable organ-at-risk sparing plans for locoregional breast radiotherapy (including the IMC) that are robust to inter-fractional changes, therefore reducing the likelihood of reactive adaptive re-planning. PMID: 31032432 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/31032432?dopt=Abstract

Source: Clinical Breast Cancer - April 30, 2019 Category: Cancer & Oncology Authors: Dunlop A, Colgan R, Kirby A, Ranger A, Blasiak-Wal I Tags: Clin Transl Radiat Oncol Source Type: research